EGF and prostate cancer: Recent experiments have demonstrated, in addition, that the proteolytic control of NKX3.1 expression levels in prostate cancer cells is regulated by mitogens such as epithelial growth factor (EGF) in an intracellular calcium- and protein kinase C (PKC)-sensitive manner [26].